Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Science (London, England : 1979)|September 21, 2005
Molecular genetic pathways in Parkinson's disease: a reviewShushant Jain, Nicholas W Wood, Daniel G Healy
Journal of Visualized Experiments : Jove|January 20, 2012
High content screening in neurodegenerative diseasesShushant Jain, Ronald E van Kesteren, Peter Heutink
Journal of Biomolecular Screening|July 22, 2011
The complete automation of cell culture: improvements for high-throughput and high-content screeningShushant Jain, David Sondervan, Patrizia Rizzu, et al.
Biochemical and Biophysical Research Communications|April 20, 2007
The R1441C mutation of LRRK2 disrupts GTP hydrolysisPatrick A Lewis, Elisa Greggio, Alexandra Beilina, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 5, 2024
Drug repurposing screen for the rare disease ataxia-telangiectasiaNamrata Jayanth, Gurvan Mahé, Matthew Campbell, et al.
Lancet (London, England)|February 1, 2005
Genetic screening for a single common LRRK2 mutation in familial Parkinson's diseaseWilliam C Nichols, Nathan Pankratz, Dena Hernandez, et al.
The Journal of Biological Chemistry|April 10, 2008
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylationElisa Greggio, Ibardo Zambrano, Alice Kaganovich, et al.
Annals of Neurology|February 26, 2005
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2Dena G Hernandez, Coro Paisán-Ruíz, Aideen McInerney-Leo, et al.
Plos One|July 15, 2011
SFRS7-mediated splicing of tau exon 10 is directly regulated by STOX1A in glial cellsDaan van Abel, Dennis R Hölzel, Shushant Jain, et al.
Pageof 3